* Latest "Gene-Therapy" in the News *
- Orchard Therapeutics to Build Out Gene Therapy Manufacturing Site in Fremont, CA Genetic Engineering & Biotechnology News
- Orchard Expects to Hire 100, Expands Gene Therapy Manufacturing in Bay Area BioSpace
- Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California b3c newswire
- View full coverage on Google News
Can gene therapy offer a cure for sickle-cell disease? Genetic Literacy Project
- Gene therapy fails to show clinical activity in X-linked retinoschisis Healio
- Biogen bails on AGTC after ocular gene therapy flunks trial FierceBiotech
- Biogen backs away from AGTC after gene therapy failure BioPharma Dive
- Biogen shrugs off $1B-plus gene therapy pact after PhI/II implosion — AGTC shares crater Endpoints News
- Applied Genetic"s gene therapy fails to show effect in XLRS study Proactive Investors USA & Canada
- View full coverage on Google News
[I]n November, six months after [21-year-old Manny] Johnson became the first patient to receive an experimental therapy aimed at curing his [sickle cell] disease, ...
Gene therapy for Crigler-Najjar syndrome EurekAlert
Genethon announces dosing of the first patient with Crigler-Najjar Syndrome, a rare liver disorder, in the European phase I/II gene therapy clinical trial - CareCN.
Dan and Jennifer Gilbert commit $12 million to pioneer gene therapy research Crain's Detroit Business
Quicken Loans Founder and Chairman Dan Gilbert and his wife, Jennifer, have pledged $12 million to fund pioneering gene therapy research aimed at finding a ...
Gene therapy for sickle cell takes another step forward Health24
A new therapy targets the genetic flaw that causes sickle cell anaemia, a devastating disease that often causes early death.
Gene Therapy: New Treatments Reprogram Patients' Immune Cell SelectScience
Gene and cellular therapies are at the forefront of several recent clinical trials for many patient conditions including hematologic cancers, solid tumors and ...
Axovant in-licenses two new gene therapies, shares up 6% after hours Seeking Alpha
Axovant Sciences (AXON) is up 6% after hours in response to its announcement that it has secured exclusive global rights to two gene therapy programs from.
Polyplus-transfection(R) further expands transfection reagent portfolio for cell and gene therapy GMP production BioSpace
Published: Dec 13, 2018. Strasbourg, France – December 13, 2018 – Polyplus-transfection® SA, a biotechnology company that develops and sells innovative ...
Gene therapies could transform sickle cell disease into a curable illness Chicago Tribune
Researchers are deploying cutting-edge genetic techniques in the attempt to cure sickle cell disease.
Orchard's Gene Therapy for Rare Immune Disease Works for Over a Year Labiotech.eu
A single dose of a gene therapy developed by Orchard Therapeutics can restore immune function for at least a year in patients with X-linked chronic ...
Axovant axes neuroscience drug, focuses on gene therapies pharmaphorum
Axovant has ended development of neuroscience drug nelotanserin after it failed in a phase 2 trial in patients with dementia.
Live EBAY Auctions
Internet Search Results
Gene therapy - Wikipedia
In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989.
Gene therapy | Define Gene therapy at Dictionary.com
Gene therapy definition, the application of genetic engineering to the transplantation of genes into human cells in order to cure a disease caused by a genetic defect, as a missing enzyme. See more.
The Forever Fix: Gene Therapy and the Boy Who Saved It ...
The Forever Fix: Gene Therapy and the Boy Who Saved It and millions of other books are available for Amazon Kindle. Learn more
Gene Therapy Net - News, Conferences, Vectors, Literature ...
Gene Therapy Net is the web resource for patients and professionals interested in gene therapy. The objectives of Gene Therapy Net are to be the information resource for basic and clinical research in gene therapy, cell therapy, and genetic vaccines, and to serve as a network in the exchange of info...
Tay-Sachs Gene Therapy Consortium
The Tay-Sachs Gene Therapy Consortium was founded in 2007 to develop a safe and effective gene-based treatment for the closely related Tay-Sachs and Sandhoff diseases (subtypes of GM2 gangliosidosis).
FDA approval brings first gene therapy to the United States
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other ...
GeoGene: Gene Therapy, What it is, The process and Vectors ...
Gene Therapy What is Gene Therapy? Certain diseases are caused by faulty genes which produce defective proteins.The symptoms of genetic disease are the result of subsequent disrupted vital cell processes caused by missing or defective proteins.
AveXis: A Clinical-Stage Gene Therapy Company
AveXis, now a Novartis Company, is a clinical-stage gene therapy company relentlessly focused on bringing gene therapy out of the lab and into the clinical setting for patients and families devastated by rare and life-threatening neurological genetic diseases.
F.D.A. Approves First Gene-Altering Leukemia Treatment ...
The Food and Drug Administration approved the first treatment that genetically alters a patient’s own cells to fight cancer. It will cost $475,000.
Cellular & Gene Therapy Guidances
Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs); Draft Guidance for Industry (PDF - 578KB) July 2018 (Corrected July 20 ...